2021
DOI: 10.1016/j.arth.2020.12.018
|View full text |Cite
|
Sign up to set email alerts
|

Alpha-Defensin Offers Limited Utility in Routine Workup of Periprosthetic Joint Infection

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
3
0
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 17 publications
(4 citation statements)
references
References 22 publications
0
3
0
1
Order By: Relevance
“…Additionally, 2 systematic reviews and meta-analyses found that the laboratory-based test and the point-of-care test had comparable accuracy for the diagnosis of PJI 70,74 . However, 3 recent studies have shown no additional benefit to the routine measurement of alpha-defensin as its diagnostic accuracy was comparable with those of other readily available synovial markers such as the WBC count and PMN% [75][76][77] . Furthermore, alpha-defensin has high false-positive rates in patients who develop metallosis following TJA.…”
Section: Alpha-defensinmentioning
confidence: 99%
“…Additionally, 2 systematic reviews and meta-analyses found that the laboratory-based test and the point-of-care test had comparable accuracy for the diagnosis of PJI 70,74 . However, 3 recent studies have shown no additional benefit to the routine measurement of alpha-defensin as its diagnostic accuracy was comparable with those of other readily available synovial markers such as the WBC count and PMN% [75][76][77] . Furthermore, alpha-defensin has high false-positive rates in patients who develop metallosis following TJA.…”
Section: Alpha-defensinmentioning
confidence: 99%
“…16 Synovial AD has initially been reported to have a high sensitivity and specificity > 95%, [17][18][19] but recent studies have shown lower diagnostic accuracy. [20][21][22][23][24] PMN are classically reported as a percentage of WBC in synovial fluid analysis, with optimal thresholds ranging from > 64% PMN to > 80% PMN. 11,14,15 In addition, there are ongoing efforts to improve the diagnosis of PJI.…”
Section: Introductionmentioning
confidence: 99%
“…Alpha-defensin is such an example but has important limitations. It is not only too expensive to merit routine use (Kleeman-Forsthuber et al, 2021), but it has also been shown to have limited sensitivity if you use more sensitive definitions such as the EBJIS (Renz et al, 2018). We have previously shown that adding simple, inexpensive biomarkers that we can easily measure in our laboratory, such as synovial fluid C-reactive protein (CRP), adenosine deaminase (ADA), and alpha-2-macrogloblulin (A2M), does contribute to more accurate diagnosis (Sousa et al, 2017).…”
Section: Introductionmentioning
confidence: 99%